α-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region

References

• Harteveld CL, Higgs DR. α-Thalassaemia. Orphanet J Rare Dis. 2010;5(1):13.
   PubMed Web of Science ®Google Scholar
• Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101(3):791–800.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
   PubMed Web of Science ®Google Scholar
• Alkindi S, Al Zadjali S, Al Madhani A, et al. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin. 2010;34(2):135–144.
   PubMed Web of Science ®Google Scholar
• Baysal E. α-Thalassemia syndromes in the United Arab Emirates. Hemoglobin. 2011;35(5–6):581–588.
   PubMed Web of Science ®Google Scholar
• Chui DH, Waye JS. Hydrops fetalis caused by α-thalassemia: an emerging health care problem. Blood. 1998;91(7):2213–2222.
   PubMed Web of Science ®Google Scholar
• Mesbah-Amroun H, Rouabhi F, Ducrocq R, et al. Molecular basis of α-thalassemia in Algeria. Hemoglobin. 2008;32(3):273–278.
   PubMed Web of Science ®Google Scholar
• Sutcharitchan P, Wang W, Settapiboon R, et al. Hemoglobin H disease classification by isoelectric focusing: molecular verification of 110 cases from Thailand. Clin Chem. 2005;51(3):641–644.
   PubMed Web of Science ®Google Scholar
• Viprakasit V, Green S, Height S, et al. Hb H hydrops fetalis syndrome associated with the interaction of two common determinants of α thalassaemia (– –MED/(alpha)T Saudi(alpha)). Br J Haematol. 2002;117(3):759–762.
   PubMed Web of Science ®Google Scholar
• Kanavakis E, Papassotiriou I, Karagiorga M, et al. Phenotypic and molecular diversity of Haemoglobin H disease: a Greek experience. Br J Haematol. 2000;111(3):915–923.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001;2(4):245–255.
   PubMed Web of Science ®Google Scholar
• Winichagoon P, Higgs D, Goodbourn S, et al. The molecular basis of α-thalassaemia in Thailand. Embo J. 1984;3(8):1813–1818.
   PubMed Web of Science ®Google Scholar
• Lau YL, Chan LC, Chan YY, et al. Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong—implications for population screening. N Engl J Med. 1997;336(18):1298–1301.
   PubMed Web of Science ®Google Scholar
• Hamamy HA, Al-Allawi NA. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013;4(2):147–167.
   PubMedGoogle Scholar
• White J, Christie B, Nam D, et al. Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis. J Med Genet. 1993;30(5):396–400.
   PubMed Web of Science ®Google Scholar
• Alkindi SS, Alzadjali S, Daar S, et al. A stepwise α-thalassemia screening strategy in high-prevalence areas. Eur J Haematol. 2013;91(2):164–169.
   PubMed Web of Science ®Google Scholar
• Wali Y, Zadjali SA, Elshinawy M, et al. Severity ranking of non deletional α thalassemic alleles: insights from an Omani family study. Eur J Haematol. 2011;86(6):507–511.
   PubMed Web of Science ®Google Scholar
• Liu YT, Old JM, Miles K, et al. Rapid detection of α-thalassaemia deletions and α-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108(2):295–299.
   PubMed Web of Science ®Google Scholar
• Baysal E. Hemoglobinopathies in the United Arab Emirates. Hemoglobin. 2001;25(2):247–253.
   PubMed Web of Science ®Google Scholar
• Baysal E, Yousef I, Zeinali M, et al. Molecular basis of haemoglobinopathies in the UAE: implications for prenatal diagnosis and prevention programmes. Emirates Med J. 2007;25(1):7–21.
   Google Scholar
• Adekile AD, Gu L-H, Baysal E, et al. Molecular characterization of α-thalassemia determinants, β-thalassemia alleles, and βS haplotypes among Kuwaiti Arabs. Acta Haematol. 1994;92(4):176–181.
   PubMed Web of Science ®Google Scholar
• Akhtar MS, Qaw F, Borgio JF, et al. Spectrum of α-thalassemia mutations in transfusion-dependent β-thalassemia patients from the Eastern Province of Saudi Arabia. Hemoglobin. 2013;37(1):65–73.
   PubMed Web of Science ®Google Scholar
• Al Moamen NJ, Thabet A, Mahdi F, et al. Various α-thalassemia genotype combinations of the Saudi-type polyadenylation signal mutation (αT-Saudiα) in the population of Bahrain: an update of genotype-phenotype analyses. Hemoglobin. 2018;42(3):166–170.
   PubMed Web of Science ®Google Scholar
• Tamaddoni A, Hadavi V, Nejad NH, et al. α-Thalassemia mutation analyses in Mazandaran Province. North Iran. Hemoglobin. 2009;33(2):115–123.
   PubMed Web of Science ®Google Scholar
• Azarkeivan A, Neishabury M, Hadavi V, et al. A report of 8 cases with Hemoglobin H disease in an Iranian family. Pediatr Hematol Oncol. 2010;27(5):405–412.
   PubMed Web of Science ®Google Scholar
• Ebrahimkhani S, Azarkeivan A, Bayat N, et al. Genotype-phenotype correlation in Iranian patients with Hb H disease. Hemoglobin. 2011;35(1):40–46.
   PubMed Web of Science ®Google Scholar
• Hadavi V, Jafroodi M, Hafezi-Nejad N, et al. α-Thalassemia mutations in Gilan Province, North Iran. Hemoglobin. 2009;33(3-4):235–241.
   PubMed Web of Science ®Google Scholar
• Hafezi-Nejad N, Khosravi M, Bayat N, et al. Characterizing a cohort of α-thalassemia couples collected during screening for hemoglobinopathies: 14 years of an Iranian experience. Hemoglobin. 2014;38(3):153–157.
   PubMed Web of Science ®Google Scholar
• Yavarian M, Karimi M, Zorai A, et al. Molecular basis of Hb H disease in southwest Iran. Hemoglobin. 2005;29(1):43–50.
   PubMed Web of Science ®Google Scholar
• Akbari MT, Izadi P, Izadyar M, et al. Molecular basis of thalassemia intermedia in Iran. Hemoglobin. 2008;32(5):462–470.
   PubMed Web of Science ®Google Scholar
• Hadavi V, Taromchi AH, Malekpour M, et al. Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007;92(7):992–993.
   PubMed Web of Science ®Google Scholar
• Rahimi Z. Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran. BioMed Res Int. 2013;2013. Article ID 803487.
   Google Scholar
• Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of Hemoglobin H disease in Chinese patients. N Engl J Med. 2000;343(8):544–550.
   PubMed Web of Science ®Google Scholar
• Lin P-C, Chang T-T, Liao Y-M, et al. Clinical features and genotypes of patients with Hemoglobin H disease in Taiwan. Lab Med. 2019;50(2):168–173.
   PubMed Web of Science ®Google Scholar
• Hadjiminas M, Zachariadis Z, Stamatoyannopoulos G. α-Thalassaemia in Cyprus. J Med Genet. 1979;16(5):363–365.
   PubMedGoogle Scholar
• Baysal E, Kleanthous M, Bozkurt G, et al. α Thalassaemia in the population of Cyprus. Br J Haematol. 1995;89(3):496–499.
   PubMed Web of Science ®Google Scholar
• Celik MM, Gunesacar R, Oktay G, et al. Spectrum of α-thalassemia mutations including first observation of – –(FIL) deletion in Hatay Province, Turkey. Blood Cells Mol Dis. 2013;51(1):27–30.
   PubMed Web of Science ®Google Scholar
• Öner C, Gürgey A, Öner R, et al. The molecular basis of Hb H disease in Turkey. Hemoglobin. 1997;21(1):41–51.
   PubMed Web of Science ®Google Scholar
• Cürük M. Hb H (β4) disease in Cukurova, Southern Turkey. Hemoglobin. 2007;31(2):265–271.
   PubMed Web of Science ®Google Scholar
• Guvenc B, Yildiz SM, Tekinturhan F, et al. Molecular characterization of α-thalassemia in Adana, Turkey: a single center study. Acta Haematol. 2010;123(4):197–200.
   PubMed Web of Science ®Google Scholar
• Al-Allawi NA, Badi AI, Imanian H, et al. Molecular characterization of α-thalassemia in the Dohuk region of Iraq. Hemoglobin. 2009;33(1):37–44.
   PubMed Web of Science ®Google Scholar
• Khelil AH, Laradi S, Miled A, et al. Clinical and molecular aspects of haemoglobinopathies in Tunisia. Clin Chim Acta. 2004;340(1-2):127–137.
   PubMed Web of Science ®Google Scholar
• Al-Awamy BH. Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies. Saudi Med J. 2000;21(1):8–17.
   PubMed Web of Science ®Google Scholar
• El-Kalla S, Baysal E. α-Thalassemia in the United Arab Emirates. Acta Haematol. 1998;100(1):49–53.
   PubMed Web of Science ®Google Scholar
• Jassim N, Al-Arrayed S, Gerard N, et al. Molecular basis of α-thalassemia in Bahrain. Bahrain Med Bull. 2001;23(1):3–7.
   Google Scholar
• Hellani A, Fadel E, El-Sadadi S, et al. Molecular spectrum of α-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Mol Biomarkers. 2009;13(2):219–221.
   PubMed Web of Science ®Google Scholar
• Haider M, Adekile AD. α2-Globin gene polyadenylation (AATAAA→AATAAG) mutation in Hemoglobin H disease among Kuwaitis. Med Princ Pract. 2005;14(1):73–76.
   PubMedGoogle Scholar
• Pressley L, Higgs D, Clegg J, et al. A new genetic basis for Hemoglobin-H disease. N Engl J Med. 1980;303(24):1383–1388.
   PubMed Web of Science ®Google Scholar
• Thein S, Wallace R, Pressley L, et al. The polyadenylation site mutation in the α-globin gene cluster. Blood. 1988;71(2):313–319.
   PubMed Web of Science ®Google Scholar
• Higgs D, Goodbourn S, Lamb J, et al. α-Thalassaemia caused by a polyadenylation signal mutation. Nature. 1983;306(5941):398–400.
   PubMed Web of Science ®Google Scholar
• Borgio JF. Molecular nature of α-globin genes in the Saudi population. SMJ. 2015;36(11):1271–1276.
   Google Scholar
• Fei Y-J, Öner R, Bözkurt G, et al. Hb H disease caused by a homozygosity for the AATAAA→AATAAG mutation in the polyadenylation site of the α2-globin gene: hematological observations. Acta Haematol. 1992;88(2-3):82–85.
   PubMed Web of Science ®Google Scholar
• Yuregir GT, Aksoy K, Çürük MA, et al. Hb H disease in a Turkish family resulting from the interaction of a deletional α-thalassaemia-1 and a newly discovered poly A mutation. Br J Haematol. 1992;80(4):527–532.
   PubMed Web of Science ®Google Scholar
• Zorai A, Abbes S, Préhu C, et al. Hb H disease among Tunisians: molecular characterization of α-thalassemia determinants and hematological findings. Hemoglobin. 2003;27(1):57–61.
   PubMed Web of Science ®Google Scholar
• Siala H, Ouali F, Messaoud T, et al. α-Thalassaemia in Tunisia: some epidemiological and molecular data. J Genet. 2008;87(3):229–234.
   PubMed Web of Science ®Google Scholar
• Paridar M, Azizi E, Keikhaei B, et al. Iranian patients with Hemoglobin H disease: genotype-phenotype correlation. Mol Biol Rep. 2019;46(5):5041–5048.
   PubMed Web of Science ®Google Scholar
• Farashi S, Bayat N, Vakili S, et al. Point mutations which should not be overlooked in Hb H disease. Expert Rev Hematol. 2016;9(1):107–113.
   PubMed Web of Science ®Google Scholar
• Zeinali S, Fallah MS, Bagherian H. Heterogeneity of Hemoglobin H disease in childhood. N Engl J Med. 2011;364(21):2070–2071.
   PubMedGoogle Scholar
• Zandian K, Nateghi J, Keikhaie B, et al. α-Thalassemia mutations in Khuzestan Province. Southwest Iran. Hemoglobin. 2008;32(6):546–552.
   PubMed Web of Science ®Google Scholar